Oberland Capital

Oberland Capital is a private investment firm, founded in 2013, that provides structured financing to companies across the global healthcare industry. The firm reports approximately $3.0–3.2 billion in assets under management and specializes in customized financing for clinical-stage and commercial-stage healthcare companies, using research-driven and quantitative methods. Oberland offers flexible capital solutions aimed at accelerating R&D, supporting commercialization, enabling acquisitions, and refinancing existing capital sources.